Creating next-generation medicine
through advanced biotechnology

reorder

Endogenous Biological
 Microparticles (EBMs): Research & Production

Product development

We manufacture Ainprose™, an endogenous biological microparticle product, at our own production facility.

*"Ainprose™ infusion therapy" is required to be performed as a medical procedure under the responsibility of medical institutions and physicians, and "Ainprose™" itself is not a drug approved under the Pharmaceutical Affairs Law.

International standards

Possibility of Ainprose.(EBMs)

Collaborative Research

Affiliated companies of this organization

NOVARK BIO株式会社

Medbis CO., Ltd

Creating next-generation medicine
through advanced biotechnology

Copyright©Advalife Science Reserved